An exception is RAGE, which was significantly reduced in participants with IPF and, in LASSO regression models, emerged as the most important biomarker in predicting case status, all three measures of pulmonary function (FVC, DLCO, and FEV1), and health-related QoL. This evidence concerns the gene AGER and idiopathic pulmonary fibrosis.